Ferring Pharmaceuticals is a specialty biopharmaceutical group headquartered in Saint-Prex, Switzerland, with a focus on reproductive medicine, gastroenterology and urology. The company was founded in 1950 by Dr. Frederik Paulsen in Malmö, Sweden, originally as Nordiska Hormon Laboratoriet, and was renamed Ferring in 1954. The name derives from the Friesian word for the islanders of Föhr, Paulsen’s native island. [1]
Design and History
The corporate wordmark for Ferring Pharmaceuticals is documented in a U.S. trademark registration held by Ferring B.V. The mark consists of a white rectangle outlined with a single black line, containing the stylized word “FERRING” in blue and the stylized word “PHARMACEUTICALS” in black, with a single black line separating the two words. [2]
Ferring B.V. has also filed separate trademark applications for a logo mark. One application, filed July 7, 2008, describes a quadrilateral with a triangle on the left side and a long thin triangle on the right side of the quadrilateral. [3] A more recent Canadian trademark filing for a logo was made by Ferring BV on February 19, 2019. [4]
Ferring’s own materials note that the FERRING and FERRING PHARMACEUTICALS logos are trademarks of Ferring B.V. [5]
Meaning and Symbolism
The documented meaning of the Ferring name is tied to the company’s founder. Frederik Paulsen chose “Ferring” because he wanted a name that would be easy to understand and pronounce in as many countries as possible, and because the Friesian word “Ferring” refers to the islanders of Föhr, reflecting his personal connection to his native island. [1] No official source documents symbolic meaning for the colors or geometric elements of the logo itself.
Logo Index is an independent educational archive covering logos, visual identities and graphic design history. All trademarks and brand assets remain the property of their respective owners.
